Sign in

CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
operating
Phone
44-0-20-3457 6900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
  1. 6-K Event Report of Foreign Issuer
  2. D Other Notice of Sales of Unregistered Securities
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 6-K Event Report of Foreign Issuer
  7. SC 13G Stake Amended Statement of Ownership
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. EFFECT Other Notice of Effectiveness
  14. POS AM Other Post-effective Amendment for Registration Statement
  15. 6-K Event Report of Foreign Issuer
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 6-K Event Report of Foreign Issuer
  18. 424B4 Offering Prospectus
  19. CERT Other Certification
  20. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit

Page 13 of 14 · 278 filings